Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.02 | N/A |
| PEG Ratio (TTM) | 3.17 | N/A |
| P/S Ratio (TTM) | 2.43 | N/A |
| P/B Ratio (TTM) | 1.13 | N/A |
| P/FCF Ratio (TTM) | 9.04 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.21 | N/A |
| Price to 5YR AVG FCF Ratio | 11.32 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.07% | N/A |
| ROE (TTM) | 10.76% | N/A |
| Net Profit Margin (TTM) | 22.32% | N/A |
| ROIC 5YR AVG | -40.02% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.48% | 12.35% | 9.05% |
| Revenue | 9.23% | 9.41% | 8.04% |
| Net Income | 2.32% | 12.71% | 8.93% |
| Cash Flow | 52.55% | 114.83% | 61.12% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.30 | N/A |
| Quick Ratio (TTM) | 0.30 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 1.01 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 0.12 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.11% | N/A |